What are the clinical benefits of minimally invasive spine surgery compared to open procedures?

Minimally invasive spine surgery results in reduced blood loss, lower postoperative narcotic consumption, and preservation of paraspinal muscles. By dilating rather than stripping the posterior musculature, the procedure maintains physiologic lumbar stability and may reduce the risk of adjacent-level disease over time.

How does the ACTIFUSE MIS delivery system work in tight surgical spaces?

The ACTIFUSE MIS system is a pistol-grip applicator with a 200 mm working length and 8 mm outside diameter that delivers 0.5 mL of graft per trigger squeeze. It allows precise placement around cages and screws through small incisions, with bayonet-fit refill cartridges that can be swapped mid-case without disrupting workflow.

Why is ready-to-use graft formulation important in minimally invasive spine surgery?

Ready-to-use formats like ACTIFUSE FLOW and ACTIFUSE ABX eliminate mixing delays and preparation time in the operating room, reducing non-surgical time and allowing surgeons to focus on the procedure. This efficiency benefits both surgical workflow and hospital operational costs.

Minimally Invasive Spine Surgery: How ACTIFUSE MIS Delivery System Enables Precision Placement in 450,000+ Annual U.S. Procedures

450,000+ Spinal Fusions Annually: Why Delivery System Design Matters in Minimally Invasive Surgery

As of 2026, more than 450,000 spinal fusion procedures are performed in the United States every year, with a substantial number involving the lumbar spine. What was once a specialized approach has become mainstream surgical practice. Minimally invasive surgery (MIS) techniques now account for a growing share of these cases because they offer patients clear clinical benefits. But there is a practical reality that every spine surgeon faces: MIS workflows place different demands on bone graft delivery than open procedures do. The small working corridor, limited direct visualization, and the need to place graft precisely around cages or screws mean that a standard delivery system simply is not enough. ACTIFUSE MIS was designed from the start for this exact challenge, not adapted from an open-surgery tool after the fact. Elite Surgical Technologies supplies this system and the published clinical evidence that sits behind it so that you can evaluate how a purpose-built bone graft delivery option fits into your MIS technique.

The MIS Advantage: Reduced Blood Loss, Lower Narcotic Use, and Preserved Musculature

Multiple studies have documented what you are likely seeing in your own practice: minimally invasive TLIF procedures result in reduced blood loss compared to open TLIF, and patients undergoing MIS spine surgery often consume less narcotic pain medication postoperatively. The reasons are anatomical. By working through smaller incisions and dilating rather than stripping the posterior musculature, you preserve the paraspinal muscles that contribute to physiologic lumbar stability. That preservation may, over time, reduce the risk of adjacent-level disease, a concern that drives long-term outcomes and revision rates. These advantages are real, but they depend on two things: appropriate surgical technique and the ability to deliver bone graft substitute reliably into the fusion site through the limited access you have. If the graft cannot be placed where it needs to go, the fusion environment is compromised. That is why a minimally invasive spine surgery bone graft system must be evaluated on its ability to function within these constraints, not just on the material properties of the graft itself.

Ready-to-Use Formulations: Eliminating Mixing Delays in the Operating Room

Operating room time matters, and anything that adds minutes to a case without adding value deserves scrutiny. Traditional graft preparation often requires mixing components and waiting for the material to reach the right consistency, which can interrupt the surgical flow. ACTIFUSE FLOW requires no mixing or waiting and maintains consistency throughout surgery. It is ready to use the moment you open it, and it comes in three sizes so you can choose what fits the procedure. The same philosophy extends to other formats. ACTIFUSE ABX is a sculptable putty in a preloaded syringe, ready on opening, available in sizes from 1.5 mL to 20 mL. ACTIFUSE SHAPE offers preformed moldable cylinders and strips that can be shaped to the defect and resist irrigation. All of these formulations are prepackaged and ready to use, which simplifies setup for your staff. As a point of comparison, Medtronic's Accelerate Graft Delivery System was reported in the company's release to be nine times faster than traditional graft delivery methods. While ACTIFUSE FLOW is a different system, the principle holds: ready-to-use delivery can reduce the non-surgical time spent on graft preparation, letting you focus on the procedure. For hospitals and value analysis committees, that kind of efficiency has a direct operational benefit.

Precision Placement in Small Spaces: Design for Minimally Invasive Access

The technical hurdle in MIS fusion is straightforward: you need to deliver a bone graft substitute into a small bony void through a narrow corridor, often around instrumentation, with limited ability to see the placement directly. Finger packing is not an option in that setting. The ACTIFUSE MIS delivery system was engineered for this scenario. It is a pistol-grip applicator preloaded with ACTIFUSE ABX, with a 200 mm working length and an 8 mm outside diameter. Each full trigger squeeze delivers 0.5 mL of graft in a controlled manner, and bayonet-fit refill cartridges can be swapped mid-case without disrupting your workflow. This design lets you place the graft precisely where you need it, whether you are working alongside a cage, around pedicle screws, or into a constrained interbody space. Because the system is compatible with cage and screw fixation devices commonly used in MIS TLIF and other spinal fusion procedures, it integrates into the instrumentation you already use. When you evaluate a minimally invasive spine surgery bone graft option, ask whether the delivery mechanism was built for the small-access reality of MIS or whether it is a repackaged open-surgery tool. The difference shows up in the tactile control you have during placement.

Comparing Delivery Approaches: What Surgeons Should Know

No single bone graft approach fits every patient or every procedure. Autograft remains the biologic reference standard, but harvesting adds operative time and donor-site morbidity, and the available volume is limited. Allograft offers an alternative without harvest site issues, though incorporation timelines and availability vary. BMP-2 has a defined role but comes with its own regulatory pathway, cost profile, and learning curve. In a published clinical study cited in the sources below, ACTIFUSE demonstrated fusion outcomes comparable to BMP-2, with no significant difference in the measured patient population. Synthetic bone graft substitutes like ACTIFUSE and ALTAPORE are designed as osteoconductive scaffolds with interconnected porosity and a silicate substitution to support resorption and bone replacement during healing. The ACTIFUSE MIS system gives you a way to deliver that scaffold through a minimally invasive approach with control and reproducibility. Elite Surgical Technologies does not present ACTIFUSE as a universal replacement for other bone graft materials. Rather, our role is to provide the published clinical evidence so you can make an evidence-based decision. The selection of a bone graft substitute should be driven by the patient factors in front of you, the clinical data you trust, and the procedural fit of the delivery system. If your MIS technique requires a graft that flows precisely into a deep corridor and around hardware, then a delivery system designed for that use case deserves your attention.

The Bottom Line: Purpose-Built Systems Support MIS Adoption and Outcomes

Spinal fusion is no longer an exclusively open procedure. With more than 450,000 fusions performed in the U.S. each year, minimally invasive techniques are a standard part of spine surgery. The clinical benefits you aim for, reduced blood loss, lower narcotic consumption, preservation of musculature, and possibly a lower risk of adjacent-level disease, are well documented. Those outcomes are not automatic. They depend on your surgical skill and on the tools you have in hand. A bone graft substitute that cannot be delivered reliably into the fusion bed through a small incision negates the purpose of doing the case minimally invasively. ACTIFUSE MIS is an FDA cleared system designed to solve that problem specifically for MIS workflows. It gives you a controlled, prepackaged, ready-to-use delivery format that matches the access and visualization constraints of your minimally invasive approach. When you evaluate graft options for your MIS spine cases, review the delivery system as carefully as the graft material itself. Elite Surgical Technologies provides case support in the OR, in-services your teams, and supplies clinical evidence for your hospital's value analysis committee. To see how the ACTIFUSE MIS system performs in your hands, request a case evaluation from Elite Surgical Technologies.